Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 9-10/2018

Open Access 10.01.2018 | review article

S(+)-ketamine

Current trends in emergency and intensive care medicine

verfasst von: MSc Prim. Dr. Helmut Trimmel, PD OA Dr. Raimund Helbok, Prof. Dr. Thomas Staudinger, OA Dr. Wolfgang Jaksch, OÄ Dr. Brigitte Messerer, PD OA Dr. Herbert Schöchl, MSc Prim. Prof. Dr. Rudolf Likar

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 9-10/2018

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

S(+)-ketamine, the pure dextrorotatory enantiomer of ketamine has been available for clinical use in analgesia and anesthesia for more than 25 years. The main effects are mediated by non-competitive inhibition of the N-methyl-D-aspartate (NMDA) receptor but S(+)-ketamine also interacts with opioid receptors, monoamine receptors, adenosine receptors and other purinergic receptors. Effects on α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, metabotropic glutamate receptors (mGluR) and L‑type calcium chanels have also been described. S(+)-ketamine stimulates the sympathetic nerve system, making it an ideal drug for analgosedation or induction of anesthesia in instable patients. In addition, the neuroprotective properties, bronchodilatory, antihyperalgesic or antiepileptic effects provide interesting therapeutic options. In this article we discuss the numerous effects of S(+)-ketamine under pharmacological and clinical aspects especially for typical indications in emergency medicine as well as intensive care.
Literatur
2.
Zurück zum Zitat Sleigh J, Harvey M, Voss L, Denny B. Ketamine—More mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4:76–81. CrossRef Sleigh J, Harvey M, Voss L, Denny B. Ketamine—More mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4:76–81. CrossRef
4.
Zurück zum Zitat Kolawole IK. Ketamine hydrochloride: a useful but frequently misused drug. Niger J Surg Res. 2001;3:118–25. Kolawole IK. Ketamine hydrochloride: a useful but frequently misused drug. Niger J Surg Res. 2001;3:118–25.
6.
Zurück zum Zitat Taniguchi T, Shibata K, Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology. 2001;95(4):928–32. CrossRefPubMed Taniguchi T, Shibata K, Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology. 2001;95(4):928–32. CrossRefPubMed
7.
Zurück zum Zitat Yu M, Shao D, Liu J, Zhu J, Zhang Z, Xu J. Effects of ketamine on levels of cytokines, NF-κB and TLRs in rat intestine during CLP-induced sepsis. Int Immunopharmacol. 2007;7(8):1076–82. CrossRefPubMed Yu M, Shao D, Liu J, Zhu J, Zhang Z, Xu J. Effects of ketamine on levels of cytokines, NF-κB and TLRs in rat intestine during CLP-induced sepsis. Int Immunopharmacol. 2007;7(8):1076–82. CrossRefPubMed
8.
Zurück zum Zitat Yu M, Shao D, Yang R, Feng X, Zhu S, Xu J. Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis. J Pharm Pharm Sci. 2007;10(4):434–42. CrossRefPubMed Yu M, Shao D, Yang R, Feng X, Zhu S, Xu J. Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis. J Pharm Pharm Sci. 2007;10(4):434–42. CrossRefPubMed
9.
Zurück zum Zitat Gokcinar D, Ergin V, Cumaoglu A, Menevse A, Aricioglu A. Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury. Acta Biochim Pol. 2013;60(3):451–6. PubMed Gokcinar D, Ergin V, Cumaoglu A, Menevse A, Aricioglu A. Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury. Acta Biochim Pol. 2013;60(3):451–6. PubMed
10.
Zurück zum Zitat Yoon SH. Concerns of the anesthesiologist: anesthetic induction in severe sepsis or septic shock patients. Korean J Anesthesiol. 2012;63:3–10. CrossRefPubMedPubMedCentral Yoon SH. Concerns of the anesthesiologist: anesthetic induction in severe sepsis or septic shock patients. Korean J Anesthesiol. 2012;63:3–10. CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat do Vale EM, Xavier CC, Nogueira BG, Campos BC, Aquino PEA, Costa RO, Barros Viana GS. Antinociceptive and antiinflammatory effects of Ketamine and the relationship to its antidepressant action and GSK3 inhibition. Basic Clin Pharmacol Toxicol. 2016;119(6):562–73. CrossRefPubMed do Vale EM, Xavier CC, Nogueira BG, Campos BC, Aquino PEA, Costa RO, Barros Viana GS. Antinociceptive and antiinflammatory effects of Ketamine and the relationship to its antidepressant action and GSK3 inhibition. Basic Clin Pharmacol Toxicol. 2016;119(6):562–73. CrossRefPubMed
12.
Zurück zum Zitat Långsjö JW, Maksimow A, Salmi E, Kaisti K, Aalto S, Oikonen V, Parkkola R. S‑ketamine anesthesia increases cerebral blood flow in excess of the metabolic needs in humans. Anesthesiology. 2005;103(2):258–68. CrossRefPubMed Långsjö JW, Maksimow A, Salmi E, Kaisti K, Aalto S, Oikonen V, Parkkola R. S‑ketamine anesthesia increases cerebral blood flow in excess of the metabolic needs in humans. Anesthesiology. 2005;103(2):258–68. CrossRefPubMed
13.
Zurück zum Zitat Annetta MG, Iemma D, Garisto C, Tafani C, Proietti R. Ketamine: new indications for an old drug. Curr Drug Targets. 2005;6(7):789–94. CrossRefPubMed Annetta MG, Iemma D, Garisto C, Tafani C, Proietti R. Ketamine: new indications for an old drug. Curr Drug Targets. 2005;6(7):789–94. CrossRefPubMed
15.
Zurück zum Zitat Suzuki T, Aoki T, Kato H, Yamazaki M, Misawa M. Effects of the 5‑HT 3 receptor antagonist ondansetron on the ketamine-and dizocilpine-induced place preferences in mice. Eur J Pharmacol. 1999;385(2):99–102. CrossRefPubMed Suzuki T, Aoki T, Kato H, Yamazaki M, Misawa M. Effects of the 5‑HT 3 receptor antagonist ondansetron on the ketamine-and dizocilpine-induced place preferences in mice. Eur J Pharmacol. 1999;385(2):99–102. CrossRefPubMed
16.
Zurück zum Zitat Leão AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:359–90. CrossRef Leão AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:359–90. CrossRef
17.
Zurück zum Zitat Dreier JP, Reiffurth C. The stroke-migraine depolarization continuum. Neuron. 2015;86(4):902–22. CrossRefPubMed Dreier JP, Reiffurth C. The stroke-migraine depolarization continuum. Neuron. 2015;86(4):902–22. CrossRefPubMed
19.
Zurück zum Zitat Hartings JA, Watanabe T, Bullock MR, Okonkwo DO, Fabricius M, Woitzik J, et al. Spreading depolarizations have prolonged direct current shifts and are associated with poor outcome in brain trauma. Brain. 2011;134(5):1529–40. CrossRefPubMed Hartings JA, Watanabe T, Bullock MR, Okonkwo DO, Fabricius M, Woitzik J, et al. Spreading depolarizations have prolonged direct current shifts and are associated with poor outcome in brain trauma. Brain. 2011;134(5):1529–40. CrossRefPubMed
20.
Zurück zum Zitat Hertle DN, Dreier JP, Woitzik J, Hartings JA, Bullock R, Okonkwo DO, Shutter LA, Vidgeon S, Strong AJ, Kowoll C, Dohmen C, Diedler J, Veltkamp R, Bruckner T, Unterberg AW. Sakowitz OW and for the cooperative study of brain injury depolarizations (COSBID). Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury. Brain. 2012;135:2390–8. CrossRefPubMed Hertle DN, Dreier JP, Woitzik J, Hartings JA, Bullock R, Okonkwo DO, Shutter LA, Vidgeon S, Strong AJ, Kowoll C, Dohmen C, Diedler J, Veltkamp R, Bruckner T, Unterberg AW. Sakowitz OW and for the cooperative study of brain injury depolarizations (COSBID). Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury. Brain. 2012;135:2390–8. CrossRefPubMed
21.
Zurück zum Zitat Schiefecker AJ, Beer R, Pfausler B, Lackner P, Broessner G, Unterberger I, et al. Clusters of cortical spreading depolarizations in a patient with intracerebral hemorrhage: a multimodal neuromonitoring study. Neurocrit Care. 2015;22(2):293–8. CrossRefPubMed Schiefecker AJ, Beer R, Pfausler B, Lackner P, Broessner G, Unterberger I, et al. Clusters of cortical spreading depolarizations in a patient with intracerebral hemorrhage: a multimodal neuromonitoring study. Neurocrit Care. 2015;22(2):293–8. CrossRefPubMed
22.
Zurück zum Zitat Yan J, Jiang H. Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain. J Neurosurg Anesthesiol. 2014;26(2):155–60. CrossRefPubMed Yan J, Jiang H. Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain. J Neurosurg Anesthesiol. 2014;26(2):155–60. CrossRefPubMed
23.
Zurück zum Zitat Zou X, Patterson TA, Sadovova N, Twaddle NC, Doerge DR, Zhang X, Wang C. Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci. 2009;108(1):149–58. CrossRefPubMedPubMedCentral Zou X, Patterson TA, Sadovova N, Twaddle NC, Doerge DR, Zhang X, Wang C. Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci. 2009;108(1):149–58. CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yan J, Li YR, Zhang Y, Lu Y, Jiang H. Repeated exposure to anesthetic ketamine can negatively impact neurodevelopment in infants: a prospective preliminary clinical study. J Child Neurol. 2014;29(10):1333–8. CrossRefPubMed Yan J, Li YR, Zhang Y, Lu Y, Jiang H. Repeated exposure to anesthetic ketamine can negatively impact neurodevelopment in infants: a prospective preliminary clinical study. J Child Neurol. 2014;29(10):1333–8. CrossRefPubMed
25.
Zurück zum Zitat Benrath J, Brechtel C, Stark J, Sandkühler J. Low dose of S(+)-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo. Br J Anaesth. 2005;95(4):518–23. CrossRefPubMed Benrath J, Brechtel C, Stark J, Sandkühler J. Low dose of S(+)-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo. Br J Anaesth. 2005;95(4):518–23. CrossRefPubMed
26.
Zurück zum Zitat Marland S, Ellerton J, Andolfatto G, Strapazzon G, Thomassen O, Brandner B, Paal P. Ketamine: use in anesthesia. Cns Neurosci Ther. 2013;19(6):381–9. CrossRefPubMed Marland S, Ellerton J, Andolfatto G, Strapazzon G, Thomassen O, Brandner B, Paal P. Ketamine: use in anesthesia. Cns Neurosci Ther. 2013;19(6):381–9. CrossRefPubMed
27.
Zurück zum Zitat Roessler M. Prähospitale Notfallnarkose beim Erwachsenen. Notf Rettungsmed. 2016;19(4):292–6. CrossRef Roessler M. Prähospitale Notfallnarkose beim Erwachsenen. Notf Rettungsmed. 2016;19(4):292–6. CrossRef
28.
Zurück zum Zitat Morris C, Perris A, Klein J, Mahoney P. Anaesthesia in haemodynamically compromised emergency patients: Does ketamine represent the best choice of induction agent? Anaesthesia. 2009;64(5):532–9. CrossRefPubMed Morris C, Perris A, Klein J, Mahoney P. Anaesthesia in haemodynamically compromised emergency patients: Does ketamine represent the best choice of induction agent? Anaesthesia. 2009;64(5):532–9. CrossRefPubMed
29.
Zurück zum Zitat Green SM, Roback MG, Kennedy RM, Krauss B. Clinical practice guideline for emergency department Ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449–61. CrossRefPubMed Green SM, Roback MG, Kennedy RM, Krauss B. Clinical practice guideline for emergency department Ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449–61. CrossRefPubMed
30.
Zurück zum Zitat Gündüz M, Sakallı Ş, Güneş Y, Kesiktaş E, Özcengiz D, Işık G. Comparison of effects of ketamine, ketamine-dexmedetomidine and ketamine-midazolam on dressing changes of burn patients. J Anaesthesiol Clin Pharmacol. 2011;27(2):220–4. CrossRefPubMedPubMedCentral Gündüz M, Sakallı Ş, Güneş Y, Kesiktaş E, Özcengiz D, Işık G. Comparison of effects of ketamine, ketamine-dexmedetomidine and ketamine-midazolam on dressing changes of burn patients. J Anaesthesiol Clin Pharmacol. 2011;27(2):220–4. CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat O’Hara D, Ganeshalingam K, Gerrish H, Richardson P. A 2 year experience of nurse led conscious sedation in paediatric burns. Burns. 2014;40(1):48–53. CrossRefPubMed O’Hara D, Ganeshalingam K, Gerrish H, Richardson P. A 2 year experience of nurse led conscious sedation in paediatric burns. Burns. 2014;40(1):48–53. CrossRefPubMed
32.
Zurück zum Zitat De la Grandville B, Arroyo D, Walder B. Etomidate for critically ill patients. Con: Do you really want to weaken the frail? Eur J Anaesthesiol. 2012;29:511–4. CrossRefPubMed De la Grandville B, Arroyo D, Walder B. Etomidate for critically ill patients. Con: Do you really want to weaken the frail? Eur J Anaesthesiol. 2012;29:511–4. CrossRefPubMed
33.
Zurück zum Zitat Stoelting RK, Hillier SC. Nonbarbiturate intravenous anaesthetic drugs. In: Stoelting RK, Hillier SC, editors. Pharmacology and physiology in anaesthetic practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. pp. 155–78. Stoelting RK, Hillier SC. Nonbarbiturate intravenous anaesthetic drugs. In: Stoelting RK, Hillier SC, editors. Pharmacology and physiology in anaesthetic practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. pp. 155–78.
34.
Zurück zum Zitat Corssen G, Gutierrez J, Reves JG, Huber FC. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg. 1972;51:588–96. PubMed Corssen G, Gutierrez J, Reves JG, Huber FC. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg. 1972;51:588–96. PubMed
35.
Zurück zum Zitat Zeiler FA, Teitelbaum J, Gillman LM, West M. NMDA antagonists for refractory seizures. Neurocrit Care. 2014;20(3):502–13. CrossRefPubMed Zeiler FA, Teitelbaum J, Gillman LM, West M. NMDA antagonists for refractory seizures. Neurocrit Care. 2014;20(3):502–13. CrossRefPubMed
36.
Zurück zum Zitat Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014;21(1):163–73. CrossRefPubMed Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014;21(1):163–73. CrossRefPubMed
37.
Zurück zum Zitat Heffner AC, Swords D, Kline JA, Jones AE. The frequency and significance of postintubation hypotension during emergency airway management. J Crit Care. 2012;27(4):417.e9. CrossRef Heffner AC, Swords D, Kline JA, Jones AE. The frequency and significance of postintubation hypotension during emergency airway management. J Crit Care. 2012;27(4):417.e9. CrossRef
38.
Zurück zum Zitat Miller M, Kruit N, Heldreich C, Ware S, Habig K, Reid C, Burns B. Hemodynamic response after rapid sequence induction with ketamine in out-of-hospital patients at risk of shock as defined by the shock index. Ann Emerg Med. 2016;68(2):181–8. CrossRefPubMed Miller M, Kruit N, Heldreich C, Ware S, Habig K, Reid C, Burns B. Hemodynamic response after rapid sequence induction with ketamine in out-of-hospital patients at risk of shock as defined by the shock index. Ann Emerg Med. 2016;68(2):181–8. CrossRefPubMed
39.
Zurück zum Zitat Rutkowska A, Skotnicka-Klonowicz G. Prehospital pain management in children with traumatic injuries. Pediatr Emerg Care. 2015;31(5):317–20. CrossRefPubMed Rutkowska A, Skotnicka-Klonowicz G. Prehospital pain management in children with traumatic injuries. Pediatr Emerg Care. 2015;31(5):317–20. CrossRefPubMed
40.
Zurück zum Zitat Samuel N, Steiner IP, Shavit I. Prehospital pain management of injured children: a systematic review of current evidence. Am J Emerg Med. 2015;33(3):451–4. CrossRefPubMed Samuel N, Steiner IP, Shavit I. Prehospital pain management of injured children: a systematic review of current evidence. Am J Emerg Med. 2015;33(3):451–4. CrossRefPubMed
41.
Zurück zum Zitat Sherwin TS, Green SM, Khan A, Chapman DS, Dannenberg B. Does adjunctive Midazolam reduce recovery agitation after Ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial. Ann Emerg Med. 2000;35(3):229–38. CrossRefPubMed Sherwin TS, Green SM, Khan A, Chapman DS, Dannenberg B. Does adjunctive Midazolam reduce recovery agitation after Ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial. Ann Emerg Med. 2000;35(3):229–38. CrossRefPubMed
42.
Zurück zum Zitat Wathen JE, Roback MG, Mackenzie T, Bothner JP. Does Midazolam alter the clinical effects of intravenous Ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial. Ann Emerg Med. 2000;36(6):579–88. CrossRefPubMed Wathen JE, Roback MG, Mackenzie T, Bothner JP. Does Midazolam alter the clinical effects of intravenous Ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial. Ann Emerg Med. 2000;36(6):579–88. CrossRefPubMed
44.
Zurück zum Zitat Thomas MC, Jennett-Reznek AM, Patanwala AE. Combination of Ketamine and Propofol versus either agent alone for procedural sedation in the emergency department. Am J Health Syst Pharm. 2011;68(23):2248–56. CrossRefPubMed Thomas MC, Jennett-Reznek AM, Patanwala AE. Combination of Ketamine and Propofol versus either agent alone for procedural sedation in the emergency department. Am J Health Syst Pharm. 2011;68(23):2248–56. CrossRefPubMed
45.
Zurück zum Zitat Weingart SD, Trueger NS, Wong N, Scofi J, Singh N, Rudolph SS. Delayed sequence intubation: a prospective observational study. Ann Emerg Med. 2015;65(4):349–55. CrossRefPubMed Weingart SD, Trueger NS, Wong N, Scofi J, Singh N, Rudolph SS. Delayed sequence intubation: a prospective observational study. Ann Emerg Med. 2015;65(4):349–55. CrossRefPubMed
48.
Zurück zum Zitat Bourgoin A, Albanèse J, Wereszczynski N, Charbit M, Vialet R, Martin C. Safety of sedation with ketamine in severe head injury patients:comparison with sufentanil. Crit Care Med. 2003;31(3):711–7. CrossRefPubMed Bourgoin A, Albanèse J, Wereszczynski N, Charbit M, Vialet R, Martin C. Safety of sedation with ketamine in severe head injury patients:comparison with sufentanil. Crit Care Med. 2003;31(3):711–7. CrossRefPubMed
49.
Zurück zum Zitat Chang LC, Raty SR, Ortiz J, Bailard NS, Mathew SJ. The emerging use of Ketamine for anesthesia and sedation in traumatic brain injuries. CNS Neurosci Ther. 2013;19:390–5. CrossRefPubMedPubMedCentral Chang LC, Raty SR, Ortiz J, Bailard NS, Mathew SJ. The emerging use of Ketamine for anesthesia and sedation in traumatic brain injuries. CNS Neurosci Ther. 2013;19:390–5. CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Sih K, Campbell SG, Tallon JM, Magee K, Zed PJ. Ketamine in adult emergency medicine: controversies and recent advances. Ann Pharmacother. 2011;45:1525–34. CrossRefPubMed Sih K, Campbell SG, Tallon JM, Magee K, Zed PJ. Ketamine in adult emergency medicine: controversies and recent advances. Ann Pharmacother. 2011;45:1525–34. CrossRefPubMed
51.
Zurück zum Zitat Dorandeu F. Ketamine for the treatment of (super) refractory status epilepticus? Not quite yet. Expert Rev Neurother. 2017;17(5):419–21. CrossRefPubMed Dorandeu F. Ketamine for the treatment of (super) refractory status epilepticus? Not quite yet. Expert Rev Neurother. 2017;17(5):419–21. CrossRefPubMed
52.
Zurück zum Zitat Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015;30:14–20. CrossRefPubMed Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015;30:14–20. CrossRefPubMed
53.
Zurück zum Zitat Ilvento L, Rosati A, Marini C, L’Erario M, Mirabile L, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav. 2015;49:343–6. CrossRefPubMed Ilvento L, Rosati A, Marini C, L’Erario M, Mirabile L, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav. 2015;49:343–6. CrossRefPubMed
54.
Zurück zum Zitat Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, Al-Otaibi A, Kilbride R, Sánchez Fernández I, Mendoza L, Samuel S, Zakaria A, Kalamangalam GP, Legros B, Szaflarski JP, Loddenkemper T, Hahn CD, Goodkin HP, Claassen J, Hirsch LJ, LaRoche SM, Critical Care EEG Monitoring Research Consortium. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498–503. CrossRefPubMedPubMedCentral Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, Al-Otaibi A, Kilbride R, Sánchez Fernández I, Mendoza L, Samuel S, Zakaria A, Kalamangalam GP, Legros B, Szaflarski JP, Loddenkemper T, Hahn CD, Goodkin HP, Claassen J, Hirsch LJ, LaRoche SM, Critical Care EEG Monitoring Research Consortium. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498–503. CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Grover EH, Nazzal Y. Hirsch LJ Treatment of convulsive status epilepticus. Curr Treat Options Neurol. 2016;18(3):11. CrossRefPubMed Grover EH, Nazzal Y. Hirsch LJ Treatment of convulsive status epilepticus. Curr Treat Options Neurol. 2016;18(3):11. CrossRefPubMed
58.
Zurück zum Zitat Adams HA, Werner C. Vom Razemat zum Eutomer: (S)-Ketamin—Renaissance einer Substanz? Anaesthesist. 1997;46:1026–42. CrossRefPubMed Adams HA, Werner C. Vom Razemat zum Eutomer: (S)-Ketamin—Renaissance einer Substanz? Anaesthesist. 1997;46:1026–42. CrossRefPubMed
59.
Zurück zum Zitat Adams HA. Endokrine Reaktionen nach S‑(+)-Ketamin. Anaesthesist. 1997;46(Suppl 1):S30–S7. CrossRefPubMed Adams HA. Endokrine Reaktionen nach S‑(+)-Ketamin. Anaesthesist. 1997;46(Suppl 1):S30–S7. CrossRefPubMed
60.
Zurück zum Zitat Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of Hydrocortisone and Fludrocortisone on mortality in patients with septic. JAMA. 2002;288(7):861–71. CrossRef Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of Hydrocortisone and Fludrocortisone on mortality in patients with septic. JAMA. 2002;288(7):861–71. CrossRef
61.
Zurück zum Zitat Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med. 2006;174:1319–26. CrossRefPubMed Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med. 2006;174:1319–26. CrossRefPubMed
62.
Zurück zum Zitat Lange M, Bröking K, van Aken H, Hucklenbruch C, Bone HG, Westphal M. Einsatz von Ketamin bei Sepsis und systemischen Entzündungsreaktionen. Anaesthesist. 2006;55:883–91. CrossRefPubMed Lange M, Bröking K, van Aken H, Hucklenbruch C, Bone HG, Westphal M. Einsatz von Ketamin bei Sepsis und systemischen Entzündungsreaktionen. Anaesthesist. 2006;55:883–91. CrossRefPubMed
63.
Zurück zum Zitat Beilin B, Rusabrov Y, Shapira Y, Roytblat L, Greemberg L, Yardeni IZ, Bessler H. Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth. 2007;99:522–7. CrossRefPubMed Beilin B, Rusabrov Y, Shapira Y, Roytblat L, Greemberg L, Yardeni IZ, Bessler H. Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth. 2007;99:522–7. CrossRefPubMed
64.
Zurück zum Zitat Freye E, Knüfermann V. Keine Hemmung der intestinalen Motilität nach Ketamin‑/Midazolamnarkose. Ein Vergleich zur Narkose mit Enfluran und Fentanyl/Midazolam. Anaesthesist. 1994;43:87–91. CrossRefPubMed Freye E, Knüfermann V. Keine Hemmung der intestinalen Motilität nach Ketamin‑/Midazolamnarkose. Ein Vergleich zur Narkose mit Enfluran und Fentanyl/Midazolam. Anaesthesist. 1994;43:87–91. CrossRefPubMed
65.
Zurück zum Zitat Kissin I, Bright CA, Bradley EL Jr.. The effect of Ketamine on opioid-induced acute tolerance: Can it explain reduction of opioid consumption with Ketamine-opioid analgesic combinations? Anesth Analg. 2000;91(6):1483–8. CrossRefPubMed Kissin I, Bright CA, Bradley EL Jr.. The effect of Ketamine on opioid-induced acute tolerance: Can it explain reduction of opioid consumption with Ketamine-opioid analgesic combinations? Anesth Analg. 2000;91(6):1483–8. CrossRefPubMed
66.
Zurück zum Zitat Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007;369(9566):1047–53. CrossRefPubMed Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007;369(9566):1047–53. CrossRefPubMed
67.
Zurück zum Zitat Ozkan A, Okur M, Kaya M, Kaya E, Kucuk A, Erbas M, Kutlucan L, Sahan L. Sedoanalgesia in pediatric daily surgery. Int J Clin Exp Med. 2013;6(7):576–82. PubMedPubMedCentral Ozkan A, Okur M, Kaya M, Kaya E, Kucuk A, Erbas M, Kutlucan L, Sahan L. Sedoanalgesia in pediatric daily surgery. Int J Clin Exp Med. 2013;6(7):576–82. PubMedPubMedCentral
68.
1.
Zurück zum Zitat Liu F, Paule MG, Ali S, Wang C. Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Curr Neuropharmacol. 2011;9(1):256–61. CrossRefPubMedPubMedCentral Liu F, Paule MG, Ali S, Wang C. Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Curr Neuropharmacol. 2011;9(1):256–61. CrossRefPubMedPubMedCentral
Metadaten
Titel
S(+)-ketamine
Current trends in emergency and intensive care medicine
verfasst von
MSc Prim. Dr. Helmut Trimmel
PD OA Dr. Raimund Helbok
Prof. Dr. Thomas Staudinger
OA Dr. Wolfgang Jaksch
OÄ Dr. Brigitte Messerer
PD OA Dr. Herbert Schöchl
MSc Prim. Prof. Dr. Rudolf Likar
Publikationsdatum
10.01.2018
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 9-10/2018
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-017-1299-3

Weitere Artikel der Ausgabe 9-10/2018

Wiener klinische Wochenschrift 9-10/2018 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungstipps